Medical Big Data

Precision Oncology Leader to Participate at Investment Conference

Genetron Holdings Limited

Genetron Holdings Limited (“Genetron Health” or the “Company”, Nasdaq: GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early cancer screening products and companion diagnostics development, today announced that management will host virtual investor meetings at the 24th Credit Suisse Asian Investment Conference on Mar. 26th, 2021.

Sizhen Wang, co-founder and Chief Executive Officer, will also attend a fireside chat at 3:00 pm Beijing time (3:00 am ET).

Interested parties may request more information by contacting their sales representative at Credit Suisse.

Related posts

Data Science Co. Holmusk Acquires Mental Health Analytics Provider

PR Newswire

Healthcare Data Co. Intelligent Medical Objects to Showcase Expansion

Business Wire

Insights on the Oncology Precision Medicine Global Market to 2031

PR Newswire